Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMTX Immatics N.V.

交易中 07-25 11:27:00 EDT

6.31

-0.14

-2.25%

最高6.50	最低6.31	成交量12.35万
今开6.48	昨收6.45	日振幅3.02%
总市值7.66亿	流通市值3.71亿	总股本1.22亿
成交额79.41万	换手率0.21%	流通股本5,879万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":6.305,"timestamp":1753457188350,"preClose":6.45,"halted":0,"volume":123546,"delay":0,"floatShares":58787082,"shares":121550169,"eps":-0.217211,"marketStatus":"交易中","change":-0.145,"latestTime":"07-25 11:27:00 EDT","open":6.48,"high":6.5,"low":6.305,"amount":794149.3268262,"amplitude":0.030233,"askPrice":6.32,"askSize":5,"bidPrice":6.3,"bidSize":48,"shortable":3,"etf":0,"ttmEps":-0.217211,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753473600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":6.45,"preHourTrading":{"tag":"盘前","latestPrice":6.48,"preClose":6.45,"latestTime":"08:21 EDT","volume":19,"amount":123.12,"timestamp":1753446069028},"postHourTrading":{"tag":"盘后","latestPrice":6.45,"preClose":6.45,"latestTime":"16:10 EDT","volume":5312,"amount":34262.4,"timestamp":1753387803995},"volumeRatio":1.247409,"impliedVol":0.4163,"impliedVolPercentile":0.516},"requestUrl":"/m/hq/s/IMTX","defaultTab":"news","newsList":[{"id":"2550652857","title":"Immatics N.V.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652857?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:23","pubTimestamp":1752078214,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时23分，Immatics N.V.股票出现异动，股价大幅拉升5.52%。截至发稿，该股报5.93美元/股，成交量11.3095万股，换手率0.09%，振幅4.00%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.13%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710002334a440b7dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710002334a440b7dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2545444274","title":"Immatics N.V.盘中异动 股价大跌5.08%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545444274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545444274?lang=zh_cn&edition=full","pubTime":"2025-06-24 02:44","pubTimestamp":1750704265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日02时44分，Immatics N.V.股票出现波动，股价急速下挫5.08%。截至发稿，该股报5.33美元/股，成交量98.3329万股，换手率0.81%，振幅4.10%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.47%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624024425a4b9ca57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624024425a4b9ca57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2542533537","title":"Immatics N.V.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542533537?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:13","pubTimestamp":1749651190,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时13分，Immatics N.V.股票出现波动，股价急速拉升5.08%。截至发稿，该股报6.24美元/股，成交量37.2312万股，换手率0.31%，振幅5.40%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.14%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611221310a703cc3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611221310a703cc3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2542933125","title":"Immatics N.V.盘中异动 快速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542933125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542933125?lang=zh_cn&edition=full","pubTime":"2025-06-10 01:32","pubTimestamp":1749490359,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日01时32分，Immatics N.V.股票出现异动，股价快速跳水5.03%。截至发稿，该股报5.67美元/股，成交量19.0812万股，换手率0.16%，振幅8.13%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.29%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061001323995150fb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061001323995150fb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2541863511","title":"Immatics N.V.盘中异动 股价大涨6.23%报6.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863511?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:37","pubTimestamp":1749217055,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时37分，Immatics N.V.股票出现波动，股价大幅上涨6.23%。截至发稿，该股报6.14美元/股，成交量7549股，换手率0.01%，振幅3.55%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.76%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213735977471d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213735977471d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2540079572","title":"Immatics N.V.盘中异动 早盘急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540079572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540079572?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871114,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分，Immatics N.V.股票出现波动，股价快速上涨5.01%。截至发稿，该股报5.66美元/股，成交量10.6406万股，换手率0.09%，振幅0.74%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.26%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213154a496bb77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213154a496bb77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2539298047","title":"Immatics N.V.盘中异动 下午盘股价大涨5.06%报5.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539298047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539298047?lang=zh_cn&edition=full","pubTime":"2025-05-30 03:05","pubTimestamp":1748545525,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日03时05分，Immatics N.V.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报5.40美元/股，成交量17.8053万股，换手率0.15%，振幅5.93%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.31%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053003052595073a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053003052595073a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2539640548","title":"Immatics(IMTX.US)获德银首次覆盖，给予买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539640548","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539640548?lang=zh_cn&edition=full","pubTime":"2025-05-29 02:32","pubTimestamp":1748457145,"startTime":"0","endTime":"0","summary":"Immatics(IMTX.US)获德银首次覆盖，给予买入评级, 目标价10.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29023250729090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMTX"],"gpt_icon":0},{"id":"2537583499","title":"Immatics N.V.盘中异动 下午盘急速下跌5.00%报5.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537583499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537583499?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:02","pubTimestamp":1747846960,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时02分，Immatics N.V.股票出现异动，股价急速跳水5.00%。截至发稿，该股报5.13美元/股，成交量17.9578万股，换手率0.15%，振幅5.74%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.60%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522010240976101ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522010240976101ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2536643112","title":"Immatics N.V.盘中异动 股价大跌6.81%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536643112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536643112?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:36","pubTimestamp":1747748201,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时36分，Immatics N.V.股票出现波动，股价快速下挫6.81%。截至发稿，该股报4.93美元/股，成交量1.1332万股，换手率0.01%，振幅8.51%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.03%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213641aa2c93dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213641aa2c93dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2536963604","title":"Immatics N.V.盘中异动 急速上涨5.06%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536963604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536963604?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:20","pubTimestamp":1747671654,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时20分，Immatics N.V.股票出现异动，股价急速拉升5.06%。截至发稿，该股报4.98美元/股，成交量48.2648万股，换手率0.40%，振幅7.28%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.21%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000205494fbb129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000205494fbb129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2536018591","title":"Immatics N.V.2025财年第一财季实现净利润-41.95百万美元，同比减少1167.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536018591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536018591?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584090,"startTime":"0","endTime":"0","summary":"5月19日，Immatics N.V.公布财报，公告显示公司2025财年第一财季净利润为-41.95百万美元，同比减少1167.37%；其中营业收入为19.56百万美元，同比减少40.46%，每股基本收益为-0.35美元。从资产负债表来看，Immatics N.V.总负债1.14亿美元，其中短期债务3.43百万美元，资产负债比为6.08，流动比率为0.11。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000521a6e3a84f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000521a6e3a84f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX"],"gpt_icon":0},{"id":"2535203730","title":"Immatics N.V.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535203730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535203730?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:38","pubTimestamp":1747229897,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时38分，Immatics N.V.股票出现异动，股价急速拉升5.30%。截至发稿，该股报4.57美元/股，成交量5837股，换手率0.00%，振幅0.00%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.20%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213818a6df0a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213818a6df0a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2534438737","title":"Immatics N.V.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534438737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534438737?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:39","pubTimestamp":1746797987,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时39分，Immatics N.V.股票出现异动，股价快速上涨5.07%。截至发稿，该股报4.56美元/股，成交量6390股，换手率0.01%，振幅4.84%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.49%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921394797549027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921394797549027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2533713653","title":"Immatics N.V.盘中异动 早盘股价大跌6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533713653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533713653?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:32","pubTimestamp":1746711162,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时32分，Immatics N.V.股票出现波动，股价大幅下跌6.15%。截至发稿，该股报4.12美元/股，成交量2951股，换手率0.00%，振幅2.16%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.98%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213242a6d7c3e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213242a6d7c3e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2533693686","title":"Immatics N.V.盘中异动 早盘快速下挫5.45%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533693686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533693686?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:44","pubTimestamp":1746625446,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时44分，Immatics N.V.股票出现波动，股价大幅下挫5.45%。截至发稿，该股报4.34美元/股，成交量2.3407万股，换手率0.02%，振幅7.84%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721440694ef53e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721440694ef53e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2533650529","title":"Immatics N.V.盘中异动 快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650529?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:46","pubTimestamp":1746549987,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时46分，Immatics N.V.股票出现异动，股价快速下跌5.10%。截至发稿，该股报4.84美元/股，成交量22.3508万股，换手率0.18%，振幅7.45%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为5.55%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070046279750e4e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070046279750e4e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2532847328","title":"Immatics N.V.盘中异动 早盘股价大涨5.39%报5.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532847328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532847328?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:54","pubTimestamp":1746194042,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时54分，Immatics N.V.股票出现异动，股价快速拉升5.39%。截至发稿，该股报5.28美元/股，成交量1.4736万股，换手率0.01%，振幅4.39%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.31%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502215403974d684c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502215403974d684c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2530281201","title":"Immatics N.V.盘中异动 早盘急速拉升5.31%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281201?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:00","pubTimestamp":1745848811,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时00分，Immatics N.V.股票出现波动，股价快速上涨5.31%。截至发稿，该股报4.76美元/股，成交量1.5178万股，换手率0.01%，振幅4.54%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.91%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428220012a46a9613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428220012a46a9613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2529807681","title":"Immatics N.V.盘中异动 早盘股价大涨5.32%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529807681?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415046,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Immatics N.V.股票出现异动，股价快速拉升5.32%。截至发稿，该股报4.55美元/股，成交量2019股，换手率0.00%，振幅0.00%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213047a6c53c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213047a6c53c15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immatics.com","stockEarnings":[{"period":"1week","weight":0.0386},{"period":"1month","weight":0.1857},{"period":"3month","weight":0.427},{"period":"6month","weight":0.1518},{"period":"1year","weight":-0.479},{"period":"ytd","weight":-0.0928}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.1522},{"period":"6month","weight":0.0435},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immatics N.V.于2020年3月10日成立，是一家荷兰私人有限责任公司。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.096962},{"month":2,"riseRate":0.6,"avgChangeRate":-0.049146},{"month":3,"riseRate":0.4,"avgChangeRate":-0.055575},{"month":4,"riseRate":0.6,"avgChangeRate":0.030451},{"month":5,"riseRate":0.6,"avgChangeRate":0.084766},{"month":6,"riseRate":0.8,"avgChangeRate":0.090549},{"month":7,"riseRate":1,"avgChangeRate":0.118289},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003927},{"month":9,"riseRate":0.4,"avgChangeRate":-0.019872},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06624},{"month":11,"riseRate":0.2,"avgChangeRate":-0.045034},{"month":12,"riseRate":0.6,"avgChangeRate":0.023237}],"exchange":"NASDAQ","name":"Immatics N.V.","nameEN":"Immatics N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immatics N.V.,IMTX,Immatics N.V.股票,Immatics N.V.股票老虎,Immatics N.V.股票老虎国际,Immatics N.V.行情,Immatics N.V.股票行情,Immatics N.V.股价,Immatics N.V.股市,Immatics N.V.股票价格,Immatics N.V.股票交易,Immatics N.V.股票购买,Immatics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}